The KRASG12C inhibitors in lung cancer therapy

• Κύριοι συγγραφείς: Maciej Jędrak (Συγγραφέας), Karolina Niekurzak (Συγγραφέας), Joanna Kania (Συγγραφέας), Maciej Józefiak (Συγγραφέας), Piotr Sobkiewicz (Συγγραφέας), Krzysztof Kania (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Kazimierz Wielki University, 2023-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Introduction: Lung cancer is characterized by the highest mortality among cancers and is the second most frequently diagnosed type of cancer in the world. Targeted therapies are a promising therapeutic option for patients with this disease, however, one of the most common and most malignant mutation...